Navigation Links
Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer

EAST ALTON, Ill., Nov. 30 /PRNewswire/ -- The Simmons law firm's Trent Miracle will serve on a committee dedicated to representing thousands of women that were seriously injured after taking Yaz (Yasmin), the popular birth control pill manufactured and marketed by Bayer Pharmaceuticals.

The U.S. Judicial Panel on Multidistrict Litigation has ordered that all federal Yaz and Yasmin birth control pill lawsuits be consolidated and centralized for pretrial litigation in the Southern District of Illinois under the guidance of U.S. District Judge David R. Herndon in East St. Louis. Miracle is one of 13 attorneys selected to manage the national litigation.

"We anticipate seeing as many as 10,000 cases," said Miracle, who heads up the Simmons firm's pharmaceutical litigation practice. "Unfortunately, the injuries are widespread and serious. Consolidating these lawsuits into multidistrict litigation should allow us to help these women in a manner that's both efficient and fair."

All of the cases involve allegations that the popular birth control pills containing the new progestin drospirenone increase the risk of serious and potentially life-threatening health problems, such as heart attacks, strokes, pulmonary embolisms, deep vein thrombosis, gallbladder disease, and sudden death. The complaints allege that Bayer Pharmaceuticals, which manufactures both Yaz and Yasmin, failed to adequately research their products, fraudulently concealed the risk of injury, negligently failed to warn about the degree of risk women faced, and misrepresented the safety of the drugs in comparison to other available birth control pills.

Miracle said his role on the Steering Committee will be defined in the coming months as he and other attorneys continue to gather evidence against Bayer. Earlier this year Miracle took over the Simmons firm's growing pharmaceutical practice, which already is recognized on the national stage for its groundbreaking litigation of drug and supplement cases against major pharmaceutical companies. Miracle has worked extensively litigating against the development and marketing of dangerous drugs such as Vioxx, Bextra, Ortho Evra, Ephedra and Phenylpropanolamine (PPA), Oxycontin, and others.

"When corporations put profits over safety, the legal system is often the last resort for the people that were hurt," said Miracle. "I look forward to serving on this committee and working hard to represent the interest of thousands of women who were unfairly harmed."

About Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons firm is a leading national law firm in the fight against mesothelioma. With offices in Illinois and California, the firm has represented thousands of patients and families affected by mesothelioma from all across the country. The Simmons firm is passionate about improving the lives of victims of mesothelioma and asbestos-related illnesses and has pledged over $15 million to cancer research. The firm also has practice areas in intellectual property, pharmaceutical litigation, and business litigation.

SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC

SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
2. New Study Confirms VASER Lipo Results Are Superior to Standard Liposuction
3. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
4. Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients
5. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
6. Study Confirms: Your Hidden Food Allergies Are Making You Fat
7. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
8. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
9. Sosei Confirms the Safety of SD118 in Two Phase I Trials
10. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
11. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):